Ho Mei Ling, Fu Yin Chih, Wang Gwo Jaw, Chen Hui Ting, Chang Je Ken, Tsai Tsung Hsien, Wang Chih Kuang
Department of Physiology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
J Control Release. 2008 Jun 4;128(2):142-8. doi: 10.1016/j.jconrel.2008.02.012. Epub 2008 Mar 4.
This study relates to the Bovine Serum Albumin (BSA) protein-controlled release system with Poly(lactic-glycolic acid) (PLGA) biodegradable polymer. It also has special double emulsification carriers containing alkaline material of hydroxyapatite (HAp), which can carry the hydrophilic drug effectively and sustain a controlled substance release. The controlled release strategy is based on the HAp absorption ability, which will be trapped into the core of PLGA microsphere. Besides, the acidic degradation products of PLGA polymer and basic inorganic component of HAp can be used to control the dissolution of microsphere, then resulting in protein release. We have varied the HAp amount to observe its effect on microsphere characteristics such as the particle size, surface/internal morphology, BSA entrapment efficiency, microsphere degradation, BSA in vitro release behaviour, and cell toxicity etc.
本研究涉及具有聚乳酸-乙醇酸共聚物(PLGA)可生物降解聚合物的牛血清白蛋白(BSA)蛋白质控释系统。它还具有特殊的双乳化载体,其中含有羟基磷灰石(HAp)碱性物质,能够有效运载亲水性药物并维持物质的控释。控释策略基于HAp的吸附能力,其将被困在PLGA微球的核心。此外,PLGA聚合物的酸性降解产物和HAp的碱性无机成分可用于控制微球的溶解,进而导致蛋白质释放。我们改变了HAp的用量,以观察其对微球特性的影响,如粒径、表面/内部形态、BSA包封率、微球降解、BSA体外释放行为以及细胞毒性等。